GPX3 and interstitial lung disease: As to the latter, it is worth mentioning that in all ILD patients assessed in this study, there was a non-significant trend (cf. Fig. 3E) for never-smokers to exhibit higher GPX3 levels in BALF than patients with a smoking history.